The report shows strong growth in Asian markets, with India at 8.8% CAGR, followed by China (8.7%) and South Korea (8.6%).
Y-o-Y Growth and Strong Performance in 2024 The Small Molecule API market is anticipated to exhibit a Y-o-Y growth of 4.6% in ...
Chinese pharmaceutical giant Shanghai Pharmaceuticals Holding Co. Ltd is keen on importing active pharmaceutical ingredients ...
API prices have been under pressure over the past few quarters due to weak demand and competition from China in export ...
The U.S. leads the global plant-based API market, growing at a 4.2% CAGR, powered by biotech and agri-tech advances. With CRISPR and synthetic biology, the U.S. rapidly scales plant-derived APIs for ...
Just over a year ago, New Zealand customs officials started to intercept batches of injectable medications labelled Fitaro ...
Report Ocean has published a new report on the Saudi Arabia Active Pharmaceutical Ingredients (API) Market, delivering an extensive analysis of key factors such as market restraints, drivers, and ...
Generic drugmaker Natco Pharma consolidated net profit surged 83% to ₹676.5 crore for the quarter ended September, from ₹369 ...